Comprehensive historical analysis of global market for Psoriatic Arthritis has thoroughly analyzed in this report. It offers data and insights from 2019-2022, and provides extensive market forecasts from 2023-2032 by region/country and subsectors. It covers the price, sales volume, revenue, historical growth, gross margin, and future outlooks for the Psoriatic Arthritis market.

The Global Psoriatic Arthritis Market Size was Worth around USD 11.64 Billion in 2024 And is Predicted to Grow to around USD 31.44 Billion by 2035 With a Compound Annual Growth Rate (CAGR) of 9.45% from 2025 to 2035.

The report includes growth prospects in the global Psoriatic Arthritis market by type, application, sub segement and region and QMI has compiled a comprehensive detailed research report to offer insights. The report details consumption in the Healthcare and other sectors. Regional coverage spans North America, Europe, and rest of the world including Asia Pacific.

Leading players of Psoriatic Arthritis including:

• AbbVie Inc.
• Amgen Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Novartis AG
• Eli Lilly and Company
• Pfizer, Inc.
• Samsung Biologics
• UCB S.A.
• Others  

Request To Download Free Sample copy of the report @ https://www.sphericalinsights.com/request-sample/4294

Market split by Segement, can be divided into:

By Route of Administration

• Oral
• Parenteral
• Topical

By Drug Class

• Non-steroidal Anti-inflammatory Drugs (NSAIDS)
• Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
• Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
• Others

Market segment by Region/Country including:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

Check discount for this report: https://www.sphericalinsights.com/request-discount/4294

In January 2026, Eli Lilly’s weight-loss drug Zepbound (tirzepatide), when combined with its immunology therapy Taltz (ixekizumab), significantly reduced psoriatic arthritis symptoms in obese patients compared to Taltz alone. This late-stage Phase 3b trial (TOGETHER-PsA) highlights how treating obesity can directly improve autoimmune joint disease outcomes.

In November 2025, Johnson & Johnson’s TREMFYA (guselkumab) released new long-term Phase 3b APEX trial data showing it is the only IL-23 inhibitor proven to substantially inhibit structural joint damage in patients with active psoriatic arthritis, with benefits sustained through 48 weeks.

Access full Report with Table of Content @ https://www.decisionsadvisors.com/reports/psoriatic-arthritis-market

Whats covered in the report?

• 1. Overview of the Psoriatic Arthritis market.
• 2. The current and forecasted regional (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa) market size data for the Psoriatic Arthritis market, based on segement.
• 3. Psoriatic Arthritis Market trends.
• 4. Psoriatic Arthritis Market drivers.
• 5. Analysis of major company profiles.

Reasons to buy this Market Report:

1. Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Psoriatic Arthritis market.
2. Use the SWOT analysis to determine the competitive intensity and therefore attractiveness of the emerging Psoriatic Arthritis Industry.
3. Leading company profiles reveal details of key Psoriatic Arthritis market players emerging five operations and financial performance.
4. Add weight to presentations and pitches by understanding the future growth prospects of the emerging Psoriatic Arthritis market with five year historical forecasts.
5. Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region.
6. Extensive information on factors that will amplify the growth of the Psoriatic Arthritis market over the upcoming seven years
7. Accurate estimation of the global Psoriatic Arthritis market size
8. Exact estimations of the upcoming trends and changes observed in the consumer behavior
9. Growth of the global Psoriatic Arthritis market across the North & South America, EMEA, Asia Pacific, and Latin America
10. Information about Psoriatic Arthritis market growth potential
11. In-depth analysis of the industry’s competitive landscape and detailed information vis-a-vis on various vendors
12. Furnishing of detailed information on the factors that will restrain the growth of the Psoriatic Arthritis market

About the Spherical Insights

Spherical Insights is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.

Contact Us:

Company Name: Spherical Insights

Email: sales@sphericalinsights.com

Phone: +1 303 800 4326 (US)

Follow Us: LinkedIn | Facebook | Twitter